FDA Approved: HUMATROPE — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

The FDA approved a supplemental application for HUMATROPE (somatropin) submitted by Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Growth Hormone Deficiency
• Idiopathic Short Stature
• Prader-willi Syndrome
• Small For Gestational Age
• Turner Syndrome

Drugs mentioned

• HUMATROPE (somatropin)

Snippet

SUPPL AP for HUMATROPE (SOMATROPIN)